Get Involved

Supporting projects that are beyond early-stage commercialisation, these projects were selected by a panel of industry experts based on their translational potential for commercial applications. Each project was awarded £100,000 for the duration of a year.

An antimalarial drug targeting Plasmodium phosphodiesterases to cure patients and block transmission; a new tool to combat drug resistance
Dr David Baker (LSHTM), Dr Mark Gardner (Salvensis), Dr Alan Brown (Salvensis), Dr James Duffy (Medicine for Malaria Venture) - £95,216
1 April 2020 to 28 February 2021 (Commercialisation Award BSA35)
Read More
Development of an inactivated oral yeast vaccine against poultry Eimeria
Prof Damer Blake (RVC), Prof Fiona Tomley (RVC), Prof Dirk Werling (RVC), Dr Francesca Soutter (RVC), Dr Matthew Nolan (Cambridge University), Dr Tatiana Küster (Universität Bern) - £91,479
1 March 2020 to 28 February 2021 (Commercialisation Award BSA36)
Read More
Antimicrobial eye drops with extended duration of effect and efficicacy
Prof Liam Good (RVC / Tecrea Ltd), Dr Winnie Ntowboahene (RVC), Chiara Febrarro (Tecrea Ltd), David Cook (Tecrea Ltd), John Ridden (Tecrea Ltd) - £99,939
1 March 2020 to 28 February 2021 (Commercialisation Award BSA38)
Read More
Malaria Detection Dogs
Prof James Logan (LSHTM), Prof Steve Lindsay (Durham University), Clare Guest (Medical Detection Dogs) - £95,822
1 March 2020 to 28 February 2021 (Commercialisation Award BSA39)
Read More
Optimising sugar attachment site in vaccine
Dr Jon Cuccui (LSHTM), Prof Brendan Wren (LSHTM) - £71,011
1 March 2020 to 28 February 2021 (Commercialisatio Award BSA37)
Read More